Share

All Updates

February 7, 2024

ACS CAN strongly advocated for the No Surprises Act, a law that protects people covered under most health plans from receiving surprise medical bills when they receive most emergency services and non-emergency services from out-of-network providers. There has been extensive litigation about the law, but only one case threatened the

February 6, 2024
National

Today, the American Cancer Society Cancer Action Network (ACS CAN) issued a letter to the National Institutes of Standards and Technology (NIST) commenting on the utilization of march-in rights (MIR) to lower prescription drug costs following the release of new guidance by the administration on its application.

February 6, 2024
Indiana

INDIANAPOLIS, IN – This afternoon, the Indiana Senate passed Senate Bill 273, which would ensure biomarker testing, a game changer in the fight against cancer and an essential step in accessing precision medicine treatments, is covered by more insurance plans in the Hoosier state. The following is a statement from

February 5, 2024

Cancer patients, survivors, their families and caregivers from throughout Washington gathered at the Capitol on Monday to ask legislators to support House Bill 1450, which would have expanded insurance coverage of biomarker testing and made sure as many state residents as possible have access to this technology. They were disappointed to learn that the bill did not advance through House Appropriations and so instead turned their efforts and advocacy to the 2025 session.

February 5, 2024
Pennsylvania

HARRISBURG, PA – FEBRUARY 5, 2024 – With the 2024 legislative session underway and Governor Shapiro’s budget address set for tomorrow, here is a statement from Donna Greco, American Cancer Society Cancer Action Network (ACS CAN) Pennsylvania Government Relations Director: “As Pennsylvania lawmakers return to the 2024 legislative session, ACS

February 5, 2024
Washington

Those who traveled to the Capitol will continue to work with legislators to change that and urge them to get biomarker access expanded in 2025. Eventual passage of this legislation will make sure more residents have insurance coverage that allows for easy access to precision medicine.

February 5, 2024

Patient and provider groups including ACS CAN applauded the unanimous U.S. Supreme Court decision in Alliance for Hippocratic Medicine v Food and Drug Administration (FDA ), which preserved the agency’s approval of the drug mifepristone. The Court’s ruling was based on legal standing, finding the plaintiff

February 2, 2024
National

WASHINGTON, D.C. – Today, the American Cancer Society Cancer Action Network (ACS CAN) was joined by 20 other organizations in proposing the Health and Human Services Office of Inspector General adopt a new regulatory safe harbor from the Anti-kickback Statute that would allow clinical trial sponsors to financially support

February 2, 2024
Illinois

As we approach World Cancer Day happening this Sunday and lawmakers continue their work this session, the American Cancer Society Cancer Action Network (ACS CAN) urges legislators to prioritize passing legislation to ease the burden of cancer on Illinoisans.